Popular Articles

Appeals Court Panel Says Pharmacists Must Distribute Emergency Contraception Under Washington State Regulation
A three-judge panel of the U.S. Circuit Court of Appeals for the 9th Circuit on Wednesday unanimously ruled to lift an injunction blocking Washington state officials from penalizing pharmacists who refused to dispense the emergency contraception pill Plan B, the Los Angeles Times reports (Williams, Los Angeles Times, 7/9). The panel said the district court judge who issued the injunction refused to consider women"s need for EC (Egelko, San Francisco Chronicle, 7/9). The panel"s ruling is part of a larger case before the district court involving the constitutionality of a 2007 state regulation requiring pharmacies to stock and dispense EC. Joyce Roper, an assistant attorney general for Washington state, said the appeals court ruling means that the 2007 regulation will take immediate effect.The plaintiffs in the case, Stromans -- a supermarket pharmacy owner -- and two pharmacists employed elsewhere, argued that the state regulation requiring pharmacists to stock and dispense EC violated their First Amendment right to freedom of religion (Los Angeles Times, 7/9). The regulation said that pharmacies must stock and fill legally prescribed prescriptions but allowed individual pharmacists to object on moral or religious grounds if another pharmacist was available, in person or by telephone, to fill the order (San Francisco Chronicle, 7/9). The plaintiffs argued that the regulation would force them to choose between following their religious beliefs and keeping their jobs. They contended that EC prevents implantation of a fertilized egg, which they equated with abortion. The U.S. District Court in Seattle awarded the plaintiffs the temporary injunction in November 2007, pending trial on the constitutionality of the regulation (Los Angeles Times, 7/9). Plan B contains a high dose of a drug found in most birth control pills that generally prevents ovulation or the fertilization of an egg. Recent research suggests that it does not prevent a fertilized egg from implanting in the uterus (Woodward, AP/Seattle Post-Intelligencer, 7/8). FDA in April lowered the age limit for nonprescription purchase of Plan B from 18 to 17 (San Francisco Chronicle, 7/9). Appeals Panel Returns Case to District CourtThe appeals court panel ruled that the freedom to exercise one"s religion "does not relieve an individual of the obligation to comply with a valid and neutral law of general applicability." The panel added, "Any refusal to dispense -- regardless of whether it is motivated by religion, morals, conscience, ethics, discriminatory prejudices or personal distaste for a patient -- violates the rules" (Los Angeles Times, 7/9). The panel ordered the district judge to reconsider the 2007 regulation under Supreme Court standards that allow states to pass neutral laws that may affect religious practices. According to the panel, the regulation does not aim to interfere with religious practices or beliefs and is intended to promote patients" health. In addition, the panel said the district court judge did not consider how the injunction would affect "sexually active women of childbearing age who will be denied reasonable access to Plan B" (San Francisco Chronicle, 7/9). According to the Times, the panel"s ruling could foretell future judgments in the case, including that a patient"s right to timely medication surpasses a pharmacist"s personal beliefs (Los Angeles Times, 7/9).
generic viagra online
Smoking Increases Potential For Metastatic Pancreatic Cancer
Smoking has once again been implicated in the development of advanced cancer. Exposure to nicotine by way of cigarette smoking may increase the likelihood that pancreatic ductal adenocarcinoma will become metastatic, according to researchers from the Kimmel Cancer Center at Jefferson. Their study was published in the August edition of the journal Surgery.
News of the day
PMSI Settlement SolutionsSM Appeals To CMS On Drug Review Methods In Medicare Set-Asides
PMSI Settlement Solutions, a leading solutions provider for liability and workers" compensation claims, announced its initiative to address payor concerns regarding the Centers for Medicare and Medicaid Services (CMS) new prescription drug requirement associated with Medicare Set-Asides (MSA"s). As part of this initiative, PMSI Settlement Solutions will work with government affairs experts, industry consultants and other interested payors.
Diagnostics

IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials

The following are stories from this week"s 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa: SciDev.Net: Steven Reid of the Imperial College London spoke of three prototype tests he and his colleagues have been working on that would help to increase access to CD4 count measurements for HIV-positive patients in the developing world. The prototype tests - which analyze "finger prick blood" - would allow "patients to receive their results within about 20 minutes of testing, Reid said, and could be used by untrained technicians." The cost of the tests range from $2 - $7 (Mengo, 7/23). AP/Yahoo! News: Michael Silverman, an infectious disease expert, presented HIV infection rate data in Zimbabwe, based on his survey of 18,746 pregnant women at a rural prenatal clinic from 2001 to 2008. He found the "prevalence of the virus that causes AIDS fell from 23 percent in 2001 to 11 percent at the end of 2008." The news service writes, "AIDS experts have long noted that the richest countries in Africa are also those with the highest infection rates," and "Silverman said he concluded that "a lot of the effect (of the decline in HIV infections) is from the collapsing economy."" He added, "You can"t pay the sex worker if you have no currency. It"s hard to have a concurrent relationship if you"re always in earshot of your spouse, because you can"t afford to travel." The article includes several refutations of Silverman"s theory (Faul, 7/24). Mail & Guardian: Researchers also discussed the high mortality rates caused by HIV and tuberculosis co-infection. "About 1.4-million of the 9.27-million people infected with TB worldwide are also infected with HIV, and 80 percent of the world"s co-infected live within sub-Saharan Africa, with 29 percent in South Africa alone," the newspaper writes. Gerald Friedland of Yale University said that several studies have shown antiretroviral therapy is "essential to saving the lives of those co-infected" (Kardas-Nelson, 7/23). KPBS.org: Examines South Africa"s HIV vaccine trial - a Phase I trial that will test the safety of the vaccine in humans - one of "about 30 [other] HIV vaccines undergoing clinical trials" (Goldberg, 7/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):